The United States (US) is a key future market for Brain+, and early brand building and exploration is now ongoing- Brain+ has been selected and featured as a 2022 TMC-Denmark BioBridge Partner in the new
Texas Medical Center (TMC) new 2022 Biobridge e-book. TMC is the largest medical city in the world - 7+ million people ages 65 or older had in the US dementia in 2020
- US reimbursement/price levels for Digital Therapeutics (Dtx) at
$1000 and beyond - The US market potential for DTx for dementia is estimated to be more than
$2 billion
Brain+ selected as TMC-Denmark Biobridge partner
Early US brand-building activity and exploration
The US is the biggest healthcare market in the world, and it is a market requiring significant diligence, patience, and resources to enter and be active in. Hence the work done at this point from the Brain+ side is awareness building, go-to-market research, and early explorative dialogues. The BioBridge e-book is a great example of such awareness building and a platform for future collaborations in the US. Brand awareness is also important because strategic partners, like large pharma, large DTx companies, or large US healthcare systems are known to be on the outlook for new partners or even acquisition targets, and to get on their radar can therefore be a valuable trigger, and can ultimately be a fast track to accessing both the US and the global market.
More than 7 million people ages 65 or older had dementia in 2020. If current demographic and health trends continue, more than 9 million Americans could have dementia by 2030 and nearly 12 million by 2040. (PRB.ORG). The US is also a market that generally has prices/reimbursement levels 2-3X those of
TMC- Denmark BioBridge partner e-book
(See p. 26 for Brain+)
https://www.tmc.edu/tmc-biobridge/
About
https://www.tmc.edu/about-tmc/
https://news.cision.com/brain--a-s/r/brain--begins-early-activity-and-brand-building-in-the-us,c3650708
https://mb.cision.com/Public/20893/3650708/b18750b7a8e21f1e.pdf
https://news.cision.com/brain--a-s/i/1-b-en-rgb,c3102703
(c) 2022 Cision. All rights reserved., source